• The Zoological Society Korea : Newsletter
• /
• v.18 no.2
• /
• pp.12-20
• /
• 2001

2000년도 노벨 의학상은 스웨덴의 아비스 칼슨 박사 등 3명 이 수상했다. 그들은 신경전달 물질(neurotransmitter) 중 도파민 (dopamine)과 시냅스(synapse)에 관한 연구로 항 우울제 치료제인 프로작 (prozac)을 개발하여 신경, 정신질환 치료제 개발에 기여한 공로였다. 도파민과 GABA는 신경전달 물질 중의 하나로 도파민은 운동, 정서, 행동, 희노애락 등을 조절하는 것으로 이상 분비될 때 파킨스씨병, 정신분열증, 우울증 등을 유발시킨다. GABA는 억제성 신경전달물질로 이상 분비시 간질 등을 유발시킨다. 도파민과 GABA의 분비는 시냅스 후(postsynapse) 수용체에서 그 기능이 조절된다. 그러나 마약성인 코카인, 헤로인, 몰핀, 암페타민 등 중 독성약물뿐만 아니라 일상 생활에서 흔히 접할 수 있는 흡연, 술 등에 의해서도 그 분비 이상을 초래한다. 따라서 본 논단에서는 최근 뇌신경생물 실험실에서 진행되고 있는 신경전달 물질 중에 도파민 및 GABA 분비에 대 한 연구결과를 바탕으로 소개 하고자 한다.

• The Journal of Internal Korean Medicine
• /
• v.26 no.4
• /
• pp.864-874
• /
• 2005

This study was done as a general survey on oriental medical approaches for the detoxification and treatment of narcotics addiction. The treatment of narcotics addiction comprises the detoxification and the restoration of normal health. Medical detoxification in common use nowadays is largely divided into substitution therapy using opiate detoxicants and symptomatic therapy using non-opiate detoxicants. Experimentation was done on the supposition that non-opiate detoxicants provide a more viable therapy than opiate detoxicants in the treatment of narcotics addiction, because opiate detoxicants also produce a great dependency on a narcotic. At present, although the medication of oriental medicine that includes non-opiate detoxicants is not more effective in the detoxification than the opiate detoxicants, withdrawal symptoms are slight and few and there is a very low ratio of relapse, so treatment and restoration are relatively brief. Results of this survey suggest that detoxicants derived from oriental medical approaches are safe and effective, though further development of therapy with such detoxicants will be needed to provide reliable methods of treating narcotics addiction. Based on this survey, it is hoped that many more studies will be done on the issue of medication in the field of narcotics addiction treatment.

• Journal of Life Science
• /
• v.31 no.7
• /
• pp.677-685
• /
• 2021

Cannabis sativa L. belongs to the Cannabaceae family and is an annual herbaceous flowing plant. The plants can be classified into narcotic marijuana and nonnarcotic hemp. Different parts of C. sativa L. have been used as food, medicine, cosmetics, fiber and textile. However, the use of leaf, flower, and seed of C. sativa L was forbidden in Korea in January 1977 as a result of the Cannabis Control Act due to the narcotic properties. The plant's mature stems have limited uses for the production of fiber and sheets. Recently, various cannabinoids, terpenes and essential fatty acids were identified from C. sativa L., and their safety and useful bio-activities, such as neuroprotective, anti-inflammation, antithrombosis, antiepileptic, and antimicrobial activities, and the relief of pain, have been highlighted. Furthermore, the process of reduction of tetrahydrocannabinol, a representative narcotic compound, and the isolation of cannabidiol, a nonnarcotic active compound in C. sativa L., have been determined. These findings resulted in the legalization of C. sativa L. in Korea for medical use in December 2018 and the exclusion of C. sativa L. from the narcotic list of the UN Commission on Narcotics Drugs (UNCND) in December 2020. Therefore, developments of various high-value added products have commenced worldwide. Additionally, in 2021, the Korean government deregulated special zones based on hemp. In this study, the current status and the prospect of the hemp industry, as well as essential techniques for developing new hemp products, are provided for the activation of the Korea Green-Rush.

• Journal of Arbitration Studies
• /
• v.30 no.1
• /
• pp.39-66
• /
• 2020

Under the doctrine of separability, if the party did not specifically challenge the validity of the arbitration clause, then it is presumed valid, and arbitrators would still have authority to adjudicate disputes within the scope of the arbitration clause. Further, the Primerica and Spahr decisions address whether a court or an arbitrator should adjudicate a claim that a contract containing an arbitration clause is void ab initio due to mental incapacity. If the arbitration agreement is separable, as was found in Primerica, then the "making" of the agreement is not at issue when the challenge is directed at the entire contract and arbitrators may exercise authority. If an arbitration provision is not separable from the underlying contract, as in Spahr, a defense of mental incapacity necessarily goes against both the entire contract and the arbitration agreement, so the "making" of the agreement to arbitrate is at issue, and the claim is for courts to decide. Although no bright line rule can be established to deal with challenges of lack of mental capacity to an arbitration agreement, the rule in Prima Paint should not be extended to this defense. Extending the rule in Prima Paint would force an individual with a mental incapacity to elect between challenging the entire contract and challenging arbitration. Accordingly, there should be a special set of rules outside of the context of Prima Paint to address the situation of status-based defenses, specifically mental capacity defenses, to contracts containing arbitration provisions.

• Analytical Science and Technology
• /
• v.31 no.4
• /
• pp.161-170
• /
• 2018

The epidemic of disorders associated with synthetic stimulants, such as methamphetamine (MA) and amphetamine (AP), is a health, social, legal, and financial problem. Owing to the high potential of their abuse and addiction, reliable analytical methods are required to detect and identify MA, AP, and their metabolites in biological samples. Thus, a dilute-and-shoot liquid chromatography-tandem mass spectrophotometry (LC-MS/MS) was developed for simultaneous determination of MA, 4-hydroxymethamphetamine (4HMA), AP, and 4-hydroxyamphetamine (4HA) in urine. Urine sample ($100{\mu}L$) was mixed with $50{\mu}L$ of mobile phase consisting of 0.4 % formic acid and methanol and $50{\mu}L$ of working internal-standard solution. Aliquots of $8{\mu}L$ diluted urine was injected into the LC-MS/MS system. For all analytes, chromatographic separation was performed using a C18 reversed-phase column with gradient elution and a total run time of 5 min. The identification and quantification were performed by multiple reaction monitoring (MRM). Linear least-squares regression was conducted to generate a calibration curve, with $1/x^2$ as the weighting factor. The linear ranges were 2.0-200, 1.0-800, and 10-2500 ng/mL for 4HA and 4HMA, AP, and MA, respectively. The inter- and intraday precisions were within 6.6 %, whereas the inter- and intraday accuracies ranged from -14.9 to 11.3 %. The low limits of quantification were 2.0 ng/mL (4HA and 4HMA), 1.0 ng/mL (AP), and 10 ng/mL (MA). The proposed method exhibited satisfactory selectivity, dilution integrity, matrix effect, and stability, which are required for validation. Moreover, the purification efficiency of high-speed centrifugation was clearly higher than 6-15 % for QC samples (n=5), which was higher than that of the membrane-filtration method. The applicability of the proposed method was tested by forensic analysis of urine samples from drug abusers.

• Journal of Hospice and Palliative Care
• /
• v.19 no.4
• /
• pp.322-330
• /
• 2016

Purpose: This study investigated long-term care hospital nurses' knowledge and practice of pain management and their attitudes towards the job with an ultimate aim to provide fundamental information for development of a pain education program. Methods: A cross-sectional survey was carried out with 120 nurses from four long-term care hospitals. Nurses' knowledge of and attitudes towards pain management was measured using a tool developed by Watt-Watson. To examine their pain management practice, an instrument was developed based on the pain management guidelines used by the long-term care settings. Results: For pain management knowledge, the participants gave an average of 26.2 (${\pm}13.10$) correct answers out of 40 questions. The most frequently missed question was one about subjectivity of pain, "Patients' physiological and behavioral reactions to pain hint at the presence and intensity of pain" (89.2%), and 56.7% of the nurses believed that increasing tolerance for a narcotic analgesic means addiction. Regarding attitudes towards and practice of pain management, 80.2% of the nurses used placebos to patients who complain about pain often. Conclusion: This study revealed poor level of pain management knowledge of and attitude among long-term care hospital nurses. This might negatively affect their pain management practice. From the educational perspective, nurses should be provided with education on pain management education with emphasis on the nature of pain and misuse of placebo drugs.